Brooks Laboratories Limited (BROOKS.NS)

INR 156.86

(2.0%)

Market Cap (In INR)

4.11 Billion

Revenue (In INR)

794.86 Million

Net Income (In INR)

-195.91 Million

Avg. Volume

158.37 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
73.25-185.7
PE
-
EPS
-
Beta Value
1.543
ISIN
INE650L01011
CUSIP
Y0975G108
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Prashant Rathi
Employee Count
-
Website
https://www.brookslabs.net
Ipo Date
2011-09-05
Details
Brooks Laboratories Limited manufactures and sells pharmaceuticals on contract basis in India and internationally. It offers carbapenem drugs; tablets; dry syrup; liquid and dry power injections; and eye and ear drop. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.